{
    "2019-02-01": [
        [
            {
                "time": "2019-02-01",
                "original_text": "Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines",
                "features": {
                    "keywords": [
                        "Merck",
                        "Q4 Earnings",
                        "Sales",
                        "Keytruda"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "TTNP",
                        "CTIC",
                        "OPK",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Q4 Earnings",
                        "Pipeline Updates",
                        "PFE",
                        "RHHBY"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Watch These Healthcare Stocks in First Week of February",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "First Week",
                        "February"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "A Look at Johnson & Johnsonâ€™s Dividends and Share Repurchases",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Dividends",
                        "Share Repurchases"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Missouri Supreme Court suspends second talc cancer trial in weeks",
                "features": {
                    "keywords": [
                        "Missouri Supreme Court",
                        "talc cancer trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study",
                "features": {
                    "keywords": [
                        "J&J",
                        "Erleada",
                        "Primary Endpoints",
                        "Late-Stage Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "9 Best Dividend Stocks to Buy for Every Investor",
                "features": {
                    "keywords": [
                        "Dividend Stocks",
                        "Buy",
                        "Investor"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends",
                        "investing"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}